- Home
- OMGA vs PNI Comparison
OMGA vs PNI Comparison
Compare OMGA & PNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMGA
- PNI
- Stock Information
- Founded
- OMGA 2017
- PNI 2002
- Country
- OMGA United States
- PNI United States
- Employees
- OMGA N/A
- PNI N/A
- Industry
- OMGA Biotechnology: Pharmaceutical Preparations
- PNI Trusts Except Educational Religious and Charitable
- Sector
- OMGA Health Care
- PNI Finance
- Exchange
- OMGA Nasdaq
- PNI Nasdaq
- Market Cap
- OMGA 74.5M
- PNI 82.8M
- IPO Year
- OMGA 2021
- PNI N/A
- Fundamental
- Price
- OMGA $0.92
- PNI $7.38
- Analyst Decision
- OMGA Strong Buy
- PNI
- Analyst Count
- OMGA 5
- PNI 0
- Target Price
- OMGA $10.20
- PNI N/A
- AVG Volume (30 Days)
- OMGA 399.1K
- PNI 26.4K
- Earning Date
- OMGA 11-19-2024
- PNI 01-01-0001
- Dividend Yield
- OMGA N/A
- PNI 4.76%
- EPS Growth
- OMGA N/A
- PNI N/A
- EPS
- OMGA N/A
- PNI N/A
- Revenue
- OMGA $6,314,000.00
- PNI N/A
- Revenue This Year
- OMGA $127.25
- PNI N/A
- Revenue Next Year
- OMGA N/A
- PNI N/A
- P/E Ratio
- OMGA N/A
- PNI N/A
- Revenue Growth
- OMGA 142.47
- PNI N/A
- 52 Week Low
- OMGA $0.89
- PNI $6.03
- 52 Week High
- OMGA $6.30
- PNI $7.89
- Technical
- Relative Strength Index (RSI)
- OMGA 36.06
- PNI 45.15
- Support Level
- OMGA $1.06
- PNI $7.27
- Resistance Level
- OMGA $1.17
- PNI $7.54
- Average True Range (ATR)
- OMGA 0.11
- PNI 0.07
- MACD
- OMGA -0.02
- PNI 0.01
- Stochastic Oscillator
- OMGA 2.25
- PNI 62.67
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.
About PNI Pimco New York Municipal Income Fund II of Beneficial Interest
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.